Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Biology and Treatment of Chronic Myelogenous Leukemia
Helen Enright
, Philip B. Mcglave
Medicine - Hematology, Oncology, Transplant
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Biology and Treatment of Chronic Myelogenous Leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Progenitor Cell
100%
Cell-Cell Interaction
50%
Tyrosine Kinase
50%
Hematopoiesis
50%
Stem Cell
50%
Overall Survival
50%
Cytogenetics
50%
Chromosome 22
50%
Cell Proliferation
50%
Intron
50%
Chromosome 9
50%
Long Term Survival
50%
Bone Marrow Culture
50%
Receptor Tyrosine Kinase
50%
Interferon
50%
Programmed Cell Death
50%
Keyphrases
Chronic Myeloid Leukemia
100%
Marrow Transplantation
60%
BCR-ABL
40%
Cell Proliferation
20%
Allogeneic
20%
Stem Cells
20%
Ex Vivo Expansion
20%
Reperfusion
20%
Disease Course
20%
Interferon-α (IFN-α)
20%
Cell Interaction
20%
Chronic Phase
20%
Young Patients
20%
Overall Survival
20%
Myeloid Cells
20%
Leukemia Therapy
20%
Chromosome 22
20%
Unrelated Donor
20%
Apoptosis Inhibition
20%
Chromosome 9
20%
Clonal Expansion
20%
Long-term Survival
20%
Tyrosine Kinase Activity
20%
Survival Benefit
20%
Cell-Associated
20%
Molecular Events
20%
Hemopoiesis
20%
Complete Cytogenetic Response
20%
Intron A
20%
Stromal Progenitor Cells
20%
Hematological Response
20%
Future Therapies
20%
Haemopoietic Progenitor Cells
20%
Matched Unrelated Donor
20%
Hemopoietic Cells
20%
Medicine and Dentistry
Chronic Myelogenous Leukemia
100%
Progenitor Cell
40%
Ex Vivo
20%
In Vitro
20%
Cell Interaction
20%
Programmed Cell Death
20%
Abelson Kinase
20%
Cell Proliferation
20%
Stem Cell
20%
Protein Tyrosine Kinase
20%
Myeloid Cell
20%
Chromosome 9
20%
Overall Survival
20%
Long Term Survival
20%
Chromosome 22
20%
Recombinant Alpha2b Interferon
20%
Interferon Alfa
20%
Recombinant Alpha2a Interferon
20%
Cell Line
20%
Hematopoiesis
20%
Diseases
20%
Pathogenesis
20%
Immunology and Microbiology
Recombinant Alpha2a Interferon
100%